Cardiol Therapeutics Inc is a clinical-stage biotechnology company developing therapies for inflammatory heart disease. The company has received approval to commence a Phase II/III clinical trial investigating its product, CardiolRx, in COVID-19 patients with history of cardiovascular disease. CardiolRx is a pharmaceutically produced, GMP certified, THC free (<10 ppm) oral cannabidiol formulation.

Related Companies

TickerCompanyChg %Mkt Cap
CRTPFCardiol Therapeutics-0.19%87.7M

Cardiol Therapeutics Company Questions & Answers

Q

How do I buy Cardiol Therapeutics (CRTPF) stock?

A

You can purchase shares of Cardiol Therapeutics (OTC: CRTPF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cardiol Therapeutics's (CRTPF) main competitors?

A

There are no as such competitors for Cardiol Therapeutics.

Q

What is the target price for Cardiol Therapeutics?

A

There is no analysis for Cardiol Therapeutics

Q

How much is Cardiol Therapeutics (CRTPF) stock ?

A

The stock price for Cardiol Therapeutics (OTC: CRTPF) is $2.67 last updated Today at 7:52:26 PM.

Q

When is the next Cardiol Therapeutics (CRTPF) dividend?

A

There are no upcoming dividends for Cardiol Therapeutics.

Q

When is Cardiol Therapeutics (OTC:CRTPF) reporting earnings?

A

There are no earnings for Cardiol Therapeutics

Q

When is the upcoming split for CRTPF?

A

There is no upcoming split for Cardiol Therapeutics.